Skip to main content

TP53 alterations and colorectal cancer predisposition in south Indian population: A case-control study

Tumor Biology volume 35, pages 2303–2311 (2014)Cite this article

Abstract

The objective of the present study was to investigate the association between TP53 gene single nucleotide polymorphisms (SNPs) and colorectal cancer (CRC) predisposition in south Indian population and to evaluate the role of TP53 expression in the pathophysiology of CRC. A genetic association study was conducted in 103 CRC cases and 107 controls of south Indian origin. We genotyped ten selected TP53 SNPs by polymerase chain reaction-sequencing analysis. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D′) for pairwise linkage disequilibrium (LD) were assessed by Haploview Software. In addition, to better understand the role of TP53 in the pathophysiology of CRC, the expression pattern was evaluated in analogous tumor and normal tissues from 23 CRC patients by Western blot analysis. The frequencies of Pro72Pro (P = 0.0033) genotype and Ser47/Pro72 (P = 0.00171) haplotype were significantly higher in patients as compared to controls. Strong LD was observed between codon 47 and 72 in cases (D′ = 0.32) as compared to controls (D′ = 0.21). The polymorphism was not observe at the remaining eight SNPs loci analyzed. Furthermore, increased TP53 expression was observed in tumor tissue than in analogous normal tissue of CRC patients. Interestingly, advanced stage tumors showed more elevated TP53 expression compared to early stage tumors. In conclusion, the TP53 Pro72Pro genotype and Ser47/Pro72 haplotype has an increased risk for CRC predisposition in south Indian population. In addition, elevated TP53 expression appears to be useful prognostic marker for CRC.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–78.

    PubMed  Article  Google Scholar 

  2. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769–80.

    PubMed  Article  CAS  Google Scholar 

  3. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.

    Article  CAS  Google Scholar 

  4. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449–60.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  5. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95–107.

    PubMed  Article  CAS  Google Scholar 

  6. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9:749–58.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  7. Naccarati A, Polakova V, Pardini B, Vodickova L, Hemminki K, Kumar R, et al. Mutations and polymorphisms in TP53 gene—an overview on the role in colorectal Cancer. Mutagenesis. 2012;27:211–8.

    PubMed  Article  CAS  Google Scholar 

  8. Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.

    PubMed  Article  CAS  Google Scholar 

  9. Soussi T, Klas GW. Shaping 0Cancer Cell. 2007;12:303–12.

    Article  CAS  Google Scholar 

  10. Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet. 1993;53:752–9.

    PubMed Central  PubMed  CAS  Google Scholar 

  11. Li X, Dumont P, Della PA, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. J Biol Chem. 2005;280:24245–51.

    PubMed  Article  CAS  Google Scholar 

  12. Govatati S, Chakravarty B, Deenadayal M, Kodati VL, Latha M, Shivaji S, et al. p53 and risk of endometriosis in Indian women. Genet Test Mol Biomarkers. 2012;16(8):865–73.

    PubMed  Article  CAS  Google Scholar 

  13. Sameer AS, Shah ZA, Syeed N, Banday MZ, Bashir SM, Bhat BA, et al. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res. 2010;9:651–60.

    PubMed  Article  CAS  Google Scholar 

  14. International Union Against Cancer (UICC). In: Hermaek P, Hutter RVP, Sobin LH, editors. TNM classification of malignant tumours. Berlin: Springer-Verlag; 1998.

    Google Scholar 

  15. Govatati S, Tipirisetti NR, Perugu S, Kodati VL, Deenadayal M, Vishnupriya S, et al. Mitochondrial genome variations in advanced stage endometriosis: a study in South Indian population. PLoS ONE. 2012;7(7):e40668.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  16. Govatati S, Deenadayal M, Shivaji S, Bhanoori M. Mitochondrial d-loop alterations are associated with endometriosis. Fertil Steril. 2013;99(7):1980–6.e9.

    PubMed  Article  CAS  Google Scholar 

  17. Govatati S, Tangudu NK, Deenadayal M, Chakravarty B, Shivaji S, Bhanoori M. Association of E-cadherin single nucleotide polymorphisms with the increased risk of Endometriosis in Indian women. Mol Hum Reprod. 2012;18(5):280–7.

    PubMed  Article  CAS  Google Scholar 

  18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.

    PubMed  Article  CAS  Google Scholar 

  19. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, et al. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer. 2008;8:32.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  20. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 1997;15:887–98.

    PubMed  Article  CAS  Google Scholar 

  21. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex. Nat Cell Biol. 2004;6:443–50.

    PubMed  Article  CAS  Google Scholar 

  22. Gallego MG, Acenero MJ, Ortega S, Delgado AA, Cantero JL. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma. Dis Colon Rectum. 2000;43:971–5.

    PubMed  Article  CAS  Google Scholar 

  23. Lanza Jr G, Maestri I, Dubini A, Gafa R, Santini A, Ferretti S, et al. p53 expression in colorectal cancer: relation to tumour type, DNA ploidy pattern and short-term survival. Am J Clin Pathol. 1996;105:604–12.

    PubMed  Google Scholar 

  24. Kressner U, Lindmark G, Gerdin B, Pahlman L, Glimelius B. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res. 1996;16:951–7.

    PubMed  CAS  Google Scholar 

  25. Kressner U, Inganas M, Byding S, Blikstad I, Pahlman L, Glimelius B, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol. 1999;17:593–9.

    PubMed  CAS  Google Scholar 

  26. Bai L, Zhu WG. p53: structure, function and therapeutic applications. J Cancer Mol. 2006;2(4):141–53.

    CAS  Google Scholar 

  27. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2:594–604.

    PubMed  Article  CAS  Google Scholar 

  28. Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L, et al. P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis. 1995;16:1461–4.

    PubMed  Article  CAS  Google Scholar 

  29. Stock RS, Boltze C, Peters B, Szibor R, Landt O, Meyer F, et al. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia. 2004;6:529–35.

    Article  CAS  Google Scholar 

  30. Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutiérrez-Enríquez S, et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene. 2004;23:1954–6.

    PubMed  Article  CAS  Google Scholar 

  31. Sotamaa K, Liyanarachchi S, Mecklin JP, Jarvinen H, Aaltonen LA, Peltomaki P, et al. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res. 2005;11:6840–4.

    PubMed  Article  CAS  Google Scholar 

  32. Buyru N, Tezol A, Dalay N. p53 intronic G13964C variant in colon cancer and its association with HPV. Anticancer Res. 2005;25:2767–9.

    PubMed  CAS  Google Scholar 

  33. Kruger S, Bier A, Engel C, Mangold E, Pagenstecher C, von Knebel Doeberitz M, et al. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). J Med Genet. 2005;42:769–73.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  34. Perfumo C, Bonelli L, Menichini P, Inga A, Gismondi V, Ciferri E, et al. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. Digestion. 2006;74:228–35.

    PubMed  Article  CAS  Google Scholar 

  35. Perez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol. 2006;12:1426–9.

    PubMed  CAS  Google Scholar 

  36. Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119:1863–8.

    PubMed  Article  CAS  Google Scholar 

  37. Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S, Harris CC. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer. 2006;118:1790–7.

    PubMed Central  PubMed  Article  CAS  Google Scholar 

  38. Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, et al. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol. 2007;37:385–90.

    PubMed  Article  Google Scholar 

  39. Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene–environment interaction? Pharmacogenet Genomics. 2007;17:639–45.

    PubMed  Article  CAS  Google Scholar 

  40. Mammano E, Belluco C, Bonafe M, Olivieri F, Mugianesi E, Barbi C, et al. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol. 2009;35:415–9.

    PubMed  Article  CAS  Google Scholar 

  41. Dakouras A, Nikiteas N, Papadakis E, Perakis M, Valis D, Rallis G, et al. P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek–Caucasian population. Anticancer Res. 2008;28:1039–43.

    PubMed  CAS  Google Scholar 

  42. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, et al. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis. 2008;23:147–54.

    PubMed  Article  Google Scholar 

  43. Csejtei A, Tibold A, Vargas Z, Kola K, Ember A, Orsos Z, et al. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Res. 2008;28:1917–22.

    PubMed  CAS  Google Scholar 

  44. Polakova V, Pardini B, Naccarati A, Landi S, Slyskova J, Novotny J, et al. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat. 2009;30:661–8.

    PubMed  Article  CAS  Google Scholar 

  45. Cao Z, Song JH, Park YK, Maeng EJ, Nam SW, Lee JY, et al. The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma. 2009;56:114–8.

    PubMed  Article  CAS  Google Scholar 

  46. Joshi AM, Budhathoki S, Ohnaka K, Mibu R, Tanaka M, Kakeji Y, et al. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka colorectal cancer study. Jpn J Clin Oncol. 2011;41:232–8.

    PubMed  Article  Google Scholar 

  47. Song HR, Kweon SS, Kim HN, et al. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer. 2011;14:242–7.

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

We deeply thank all the medical staff and study subjects involved in this study.

Conflicts of interest

None

Author information

Affiliations

  1. Department of Zoology, Acharya Nagarjuna University, Guntur, India

    Gopi Krishna Singamsetty, Anil Kumar kuraganti & Kondaiah Kassetty

  2. Department of Biochemistry, Krishna University, Nuzvid, India

    Sravanthi Malempati

  3. Department of Biotechnology, Montessori Mahila Kalasala, Acharya Nagarjuna University, Vijayawada, India

    Srichandana Bhogadhi

  4. Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India

    Ravinder Kondreddy & Naveen Kumar Tangudu

  5. Department of Biochemistry, Osmania University, Hyderabad, India

    Suresh Govatati & Manjula Bhanoori

  6. Department of Zoology, RC College, Acharya Nagarjuna University, Guntur, India

    Sowdamani Govatati

Authors
  1. Gopi Krishna Singamsetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sravanthi Malempati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Srichandana Bhogadhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ravinder Kondreddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suresh Govatati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naveen Kumar Tangudu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sowdamani Govatati
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anil Kumar kuraganti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Manjula Bhanoori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kondaiah Kassetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kondaiah Kassetty.

Additional information

Gopi Krishna Singamsetty and Sravanthi Malempati contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Singamsetty, G.K., Malempati, S., Bhogadhi, S. et al. TP53 alterations and colorectal cancer predisposition in south Indian population: A case-control study. Tumor Biol. 35, 2303–2311 (2014). https://doi.org/10.1007/s13277-013-1305-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1305-y

Keywords

  • TP53
  • Colorectal cancer
  • SNP
  • Haplotype
  • Expression
  • South Indian population